Education

Inherited Bleeding Disorders 101

What Is An Inherited Bleeding Disorder

Inherited bleeding disorders are genetic conditions that affect the body’s ability to form a proper blood clot. The genetic change may be passed down from a parent or occur spontaneously as a new mutation, meaning there may be no previous family history of the disorder. These conditions may be caused by missing or defective blood components, including platelets or clotting proteins, also called clotting factors.

The body produces 13 clotting factors that work together to stop bleeding. If any of these factors are deficient or do not function properly, blood clotting can be affected, resulting in a mild, moderate, or severe bleeding disorder. Symptoms may include prolonged bleeding after an injury, surgery, trauma, or menstruation. Bleeding may also occur spontaneously, without a known or identifiable cause.

Types of Inherited Bleeding Disorders

Hemophilia A

Hemophilia A, also called factor VIII (8) deficiency or classic hemophilia, is a genetic disorder caused by missing or defective factor VIII (FVIII), a clotting protein. Although it is passed down from parents to children, about 1/3 of cases found have no previous family history.

According to the US Centers for Disease Control and Prevention (CDC), hemophilia occurs in approximately 1 in 5,617 live male births. There are between 30,000 – 33,000 males with hemophilia in the US. More than half of people diagnosed with hemophilia A have the severe form. Hemophilia A is four times as common as hemophilia B. All races and ethnic groups are affected, and women can and do have hemophilia and/or bleeding disorders. Despite long-standing misconceptions about bleeding disorders in women, women’s voices and experiences are now being taken more seriously.

Find more information and resources →

 

Hemophilia B

Hemophilia B, also called factor IX (FIX) deficiency or Christmas disease, is a genetic disorder caused by missing or defective factor IX, a clotting protein. Although it is passed down from parents to children, about 1/3 of cases are caused by a spontaneous mutation, a change in a gene.

According to the US Centers for Disease Control and Prevention, hemophilia occurs in approximately 1 in 5,000 live births. There are between 30,000 – 33,000 people with hemophilia in the US. All races and ethnic groups are affected. Hemophilia B is four times less common than hemophilia A.

Find more information and resources →

 

Von Willebrand Disease

von Willebrand disease (VWD) is an inheritable bleeding disorder and people with VWD are either missing or low in the clotting protein von Willebrand factor (VWF) – or it doesn’t work as it’s supposed to. VWD is the most common bleeding disorder and occurs equally across all races and ethnicities affecting up to 1% of the US population – or approximately 1 in every 100 people. It occurs equally in men and women. However, women may be more symptomatic due to heavy menstrual bleeding. The guidelines for
VWD were updated in 2021. Click here to read the guidelines in full. To find out if you
have signs and symptoms of VWD go here.

Find more information and resources →

Inherited Platelet Disorders

Platelet disorders occur when platelets—the blood cells responsible for binding together
to form a clot—do not function properly. Platelets are tiny, irregularly shaped cell
fragments that act as the body’s first line of defense during an injury. When a blood
vessel is damaged, platelets become ” sticky ” and cluster together to plug the site, while
simultaneously attracting the proteins necessary to build a stable, permanent clot.
There are several ways this process can fail: the body may produce too few platelets,
too many, or the platelets themselves may have a structural defect that prevents them
from sticking together. Because the mechanics of platelet signaling are highly complex,
some conditions are not yet fully understood, which may result in a diagnosis of an
“unspecified platelet disorder.”

Find more information and resources →

Rare Factor Deficiencies

Rare Factor Deficiencies such as I, II, V, VII, X, XI, XII and XIII, are all rare disorders. Factor deficiencies are defined by which specific clotting protein in the blood protein is low, missing or doesn’t work properly. These very rare factor deficiencies were only identified within the last 60-70 years.

Find more information and resources →

Learn Why Access To Insurance And Comprehensive Care Matters

There is no cure for hemophilia and other related bleeding disorders. Prior to the ACA, people with bleeding disorders were discriminated against in the insurance market. Insurance plans could exclude from coverage people with preexisting conditions. The elimination of lifetime and annual limits on insurance benefits was a significant consumer protection for people living with bleeding disorders. As a result of the high-cost treatments, people with bleeding disorders would routinely hit lifetime and annual limits before the ACA.

For patients with chronic diseases like bleeding disorders out-of-pocket expenses for prescription drugs are a significant concern. The average annual cost of clotting factor therapies for a person with severe hemophilia is roughly $300,000. Medical expenses for a person with severe hemophilia can be twice that. A person with an inhibitor (an immune response to replacement clotting factor) usually has expenses over a million dollars a year.

The treatment needs of a person with a bleeding disorder last throughout their lifetime and do not typically vary during the year. Patients need access to replacement clotting factor or other non-factor therapy year-round. Even the “average” hemophilia patient incurs tens of thousands of dollars of expenses monthly due to the treatment.

The landscape of care is rapidly shifting toward newer subcutaneous “non-factor”
therapies and one-time gene therapies, which offer more convenient dosing but carry
annual list prices between $450,000 and over $3 million. While these innovations can
significantly reduce the frequency of infusions, the underlying cost of the medicine
ensures that patients continue to face high expenses and often hit their insurance out-of-pocket maximums early in the calendar year.

To learn more about current treatment options, go here.

Comprehensive Medical Care treats the whole person and the family, through continuous supervision of all the medical and psychosocial aspects of bleeding disorders. Comprehensive care is total care because every facet of the person is addressed, including their physical, emotional, psychological, educational, financial, and vocational factors. The development of comprehensive care over the past 30 years has greatly improved the quality of life for people with bleeding disorders, helping them to be more independent and productive. The hemophilia treatment center care network has also improved patients’ overall health.
Although they are called hemophilia treatment centers, HTCs provide treatment for people with VWD and other bleeding disorders and access to comprehensive care through a team of multidisciplinary healthcare professionals that emphasize prevention to help reduce or eliminate complications. Even though inherited bleeding disorders can lead to chronic health problems, people can live a long, healthy life if the disorder is managed properly. HACA and VHF collaborate closely with the 4 federally funded HTCs in Virginia. See a list of HTCs in Virginia →

How We Support The Inherited Bleeding Disorders Community

VABDF’s services and programs are designed to support individuals and families at every stage of life, from newly diagnosed children to adults navigating healthcare and everyday life with a bleeding disorder. Learn more about what we offer →

education

Education

VABDF hosts educational programs and community learning opportunities that help individuals and families better understand bleeding disorders and available resources, including scholarships and financial assistance.

group photo

Support Us

  • Make a donation.
  • Make your donation a recurring gift, no amount is too small! When you donate, check the box that says “make my donation recurring.” Monthly donors join our Hope Society, helping secure VABDF’s future and bring hope to people living with inherited bleeding disorders.
  • Spread Awareness by following and engaging with our social media channels or go here to start your own Facebook Fundraiser to benefit VABDF.
  • Sponsor an event, email info@vabdf.org for more information.
  • Join our email newsletter.